Published in 2006, a paper by Shi Wu Wen, MB, PhD, et al. titled “Selective serotonin reuptake inhibitors and adverse pregnancy outcomes” published in The American Journal of Obstetrics and Gynecology aimed “to assess the safety of the use of selective serotonin reuptake inhibitors in pregnancy.”
The Wen et al. (2006) study group included “972 pregnant women who had been given at least 1 selective serotonin reuptake inhibitor prescription in the year before delivery and 3878 pregnant women who did not receive selective serotonin reuptake inhibitors and who were matched by the year of the infant’s birth, the type of institute at birth, and the mother’s postal code from 1990 to 2000 in the Canadian province of Saskatchewan.”
Results showed that risk of low birth weight was 58% higher for children with prenatal SSRI exposure. Children exposed to SSRIs during pregnancy were also 57% more to be born preterm, had a 223% increased risk for fetal death, and nearly 400% more likely to suffer from seizures.
Since manufacturers of SSRI drugs have time and again failed to notify patients of the risks associated with their products, women all over the world have unknowingly placed their children at risk for major birth defects, and as such, a number of SSRI birth defects lawsuits have been filed.
If you or a loved one used SSRI drugs during pregnancy and your child was born with a congenital malformation, you may be entitled to financial compensation for injury endured by your family through no fault of your own.
For a free, no-obligation case consultation, or if you would like more information on SSRIs and birth defects, please do not hesitate to contact our team of SSRI birth defects lawyers at the information provided below.
At your convenience, you may reach our offices by phone at (855) 452-5529 or by e-mail at firstname.lastname@example.org. Call today and see how we can help!